USFDA lifts import alert on Divi's Vizag plant

No major financial losses for the firm due to the import alert as regulator had spared most products from action

The US Food and Drug Administration (USFDA) informed Hyderabad-based Divi's Laboratories Limited that it will be lifting import alert 66-40 and moving to close out the warning letter issued to the company's Unit-2 at Visakhapatnam.

With the latest communication the import alert issued on Divi's Vizag facility on two technical grounds comes to an end relatively quickly.

The company has not suffered any significant financial losses on account of the import alert in the past seven months as the US drug regulator had exempted most of the products from its action citing their importance for an adequate supply of drugs made